Cargando…

Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma

BACKGROUND: A growing number of investigations have suggested a close link between cancer stem cells (CSCs), epithelial-to-mesenchymal transition (EMT), and the tumor microenvironment (TME). However, the relationships between these physiological processes in bladder urothelial carcinoma (BLCA) remai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yanlong, Zhang, Xin, Huang, Xuefeng, Tang, Xiaomeng, Zhang, Menghan, Li, Ziyi, Hu, Xiaopeng, Zhang, Min, Wang, Xi, Yan, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890713/ https://www.ncbi.nlm.nih.gov/pubmed/36721217 http://dx.doi.org/10.1186/s13287-023-03239-1

Ejemplares similares

Correlation of breast cancer microcirculation construction with tumor stem cells (CSCs) and epithelial-mesenchymal transition (EMT) based on contrast-enhanced ultrasound (CEUS)
por: Leng, Xiaoling, et al.
Publicado: (2021)

Cancer stem cells (CSCs), cervical CSCs and targeted therapies
por: Huang, Ruixia, et al.
Publicado: (2016)

PRRX1 isoform PRRX1A regulates the stemness phenotype and epithelial-mesenchymal transition (EMT) of cancer stem-like cells (CSCs) derived from non-small cell lung cancer (NSCLC)
por: Sun, Lei, et al.
Publicado: (2020)

EMT, CTCs and CSCs in tumor relapse and drug-resistance
por: Mitra, Abhisek, et al.
Publicado: (2015)

MiRNA-mediated EMT and CSCs in cancer chemoresistance
por: Dong, Bing, et al.
Publicado: (2021)

CSCs in Breast Cancer—One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs
por: Sulaiman, Andrew, et al.
Publicado: (2019)

Cancer stem cells (CSCs): metabolic strategies for their identification and eradication
por: De Francesco, Ernestina M., et al.
Publicado: (2018)

Resistance to drugs and cell death in cancer stem cells (CSCs)
por: Safa, Ahmad R
Publicado: (2020)

The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer
por: Zhou, Pingting, et al.
Publicado: (2017)

Repurposing Established Compounds to Target Pancreatic Cancer Stem Cells (CSCs)
por: Renz, Bernhard W., et al.
Publicado: (2017)

Deciphering the role of microRNA 21 in cancer stem cells (CSCs)
por: Sekar, Durairaj, et al.
Publicado: (2016)

Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?
por: Kong, Dejuan, et al.
Publicado: (2011)

The Bladder Microbiome Is Associated with Epithelial–Mesenchymal Transition in Muscle Invasive Urothelial Bladder Carcinoma
por: Li, Wei Tse, et al.
Publicado: (2021)

Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
por: Phi, Lan Thi Hanh, et al.
Publicado: (2018)

Correlation between cancer stem cells (CSCs) and tumor-infiltrating lymphocytes (TILs): do TILs interact with CSCs in non-small cell lung cancer?
por: Ling, Min, et al.
Publicado: (2020)

Immune escape mechanisms and immunotherapy of urothelial bladder cancer
por: Yang, Zhao, et al.
Publicado: (2021)

Epithelial–Mesenchymal Transition (EMT)
por: Manfioletti, Guidalberto, et al.
Publicado: (2023)

Pancreatic CSCs and microenvironment
por: Ilmer, Matthias, et al.
Publicado: (2015)

Mitoketoscins: Novel mitochondrial inhibitors for targeting ketone metabolism in cancer stem cells (CSCs)
por: Ozsvari, Bela, et al.
Publicado: (2017)

Hallmarks of the cancer cell of origin: Comparisons with “energetic” cancer stem cells (e-CSCs)
por: Sotgia, Federica, et al.
Publicado: (2019)

Survival and Enrichment Analysis of Epithelial–Mesenchymal Transition Genes in Bladder Urothelial Carcinoma
por: Ali, Waleed, et al.
Publicado: (2023)

The era of personalized treatments: Updates on immunotherapy within urothelial of bladder cancer
por: Wu, Zhang-Song, et al.
Publicado: (2022)

The Therapeutic Effect of Adipose-Derived Mesenchymal Stem Cells for Radiation-Induced Bladder Injury
por: Qiu, Xuefeng, et al.
Publicado: (2016)

GRHL2 Acts as an Anti-Oncogene in Bladder Cancer by Regulating ZEB1 in Epithelial-Mesenchymal Transition (EMT) Process
por: Shen, Jingang, et al.
Publicado: (2020)

Epithelial–Mesenchymal Transition (EMT) 2021
por: Manfioletti, Guidalberto, et al.
Publicado: (2022)

Plasticity between Epithelial and Mesenchymal States Unlinks EMT from Metastasis-Enhancing Stem Cell Capacity
por: Beerling, Evelyne, et al.
Publicado: (2016)

ATLAS computing on CSCS HPC
por: Filipcic, Andrej, et al.
Publicado: (2015)

ATLAS computing on CSCS HPC
por: Hostettler, Michael Artur, et al.
Publicado: (2015)

Exploiting mitochondrial targeting signal(s), TPP and bis-TPP, for eradicating cancer stem cells (CSCs)
por: Ozsvari, Bela, et al.
Publicado: (2018)

Mitoriboscins: Mitochondrial-based therapeutics targeting cancer stem cells (CSCs), bacteria and pathogenic yeast
por: Ozsvari, Bela, et al.
Publicado: (2017)

Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy
por: De Francesco, Ernestina Marianna, et al.
Publicado: (2017)

TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133(+) A549 cell fraction
por: Tirino, V, et al.
Publicado: (2013)

Expression of epithelial-Mesenchymal transition related markers in Plasmacytoid Urothelial carcinoma of the urinary bladder
por: Nomura, Shunichiro, et al.
Publicado: (2020)

FUT7 Promotes the Epithelial–Mesenchymal Transition and Immune Infiltration in Bladder Urothelial Carcinoma
por: Liu, Mulin, et al.
Publicado: (2021)

Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation
por: Han, Shuo, et al.
Publicado: (2015)

An experimental model of the epithelial to mesenchymal transition and pro-fibrogenesis in urothelial cells related to bladder pain syndrome/interstitial cystitis
por: Jin, Xing-Wei, et al.
Publicado: (2021)

The Urothelial Transcriptomic Response to Interferon Gamma: Implications for Bladder Cancer Prognosis and Immunotherapy
por: Baker, Simon C., et al.
Publicado: (2022)

p53 regulates epithelial-mesenchymal transition (EMT) and stem cell properties through modulating miRNAs
por: Chang, Chun-Ju, et al.
Publicado: (2011)

Atropine Is a Suppressor of Epithelial–Mesenchymal Transition (EMT) That Reduces Stemness in Drug-Resistant Breast Cancer Cells
por: Ahmed, Emad A., et al.
Publicado: (2022)

Immunotherapy in the Treatment of Urothelial Bladder Cancer: Insights From Single-Cell Analysis
por: Zang, Jingyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_afhfkunde5pr8rd5p3i49lobqa